CD8A and hepatocellular carcinoma: Interestingly, increased p-STAT3 expression in the CD4+ and CD8+ T cells in peripheral blood of patients with hepatocellular carcinoma can lead to aberrant immunological surveillance, thus promoting the development of hepatocellular carcinoma [17].